Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenotype of Hereditary Xerocytosis
NCT06892171Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Mar 2025
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU Amiens-Picardie. Primary endpoints: Identification of PIEZO1 mutations at 36 months, Identification of KCNN4 mutations at 36 months and 8 more. Started Mar 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06892171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06892171.